Bone Marrow Transplant at Cleveland Clinic
Bone Marrow Transplant at Cleveland Clinic provides specialized evaluation and treatment for selected patients with serious blood disorders, blood cancers, and other conditions that may require hematopoietic stem cell transplantation. The transplant team evaluates the patient's diagnosis, disease status, overall health, and potential treatment options before developing an individualized transplant plan.
Cleveland Clinic provides multidisciplinary transplant care involving hematology, oncology, transplant specialists, laboratory medicine, supportive care, and other medical professionals as required.
Price on Request
The cost of bone marrow transplantation varies depending on the patient's diagnosis, transplant type, donor evaluation, diagnostic testing, conditioning treatment, transplantation procedure, hospitalization, medications, and follow-up care. International patients may also have additional medical coordination and assessment requirements. A personalized cost estimate can be provided after the patient's medical information has been reviewed.
A bone marrow transplant is a specialized treatment in which healthy blood-forming stem cells are infused into a patient to restore or replace damaged or diseased bone marrow.
The procedure may be used as part of treatment for selected blood cancers, bone marrow disorders, immune system conditions, and other serious diseases when transplantation is considered medically appropriate.
Bone marrow transplantation may be considered for selected patients with conditions such as:
Certain types of leukemia
Lymphoma
Multiple myeloma
Severe bone marrow disorders
Certain inherited blood disorders
Selected immune system disorders
Other serious conditions affecting blood-forming cells
The suitability of transplantation depends on the patient's diagnosis, disease status, overall health, and transplant-specific assessment.
Before transplantation, the patient undergoes a detailed medical evaluation.
The assessment may include blood tests, bone marrow examinations, imaging studies, disease-specific testing, organ function assessment, and review of previous treatments.
The transplant team uses this information to determine whether transplantation may be an appropriate treatment option.
The transplant team evaluates the patient's underlying condition and current disease status before proceeding with transplantation.
Depending on the diagnosis, assessment may include evaluation of disease response, blood counts, bone marrow findings, genetic or molecular testing, and other investigations considered clinically appropriate.
An autologous transplant uses the patient's own blood-forming stem cells. Stem cells are collected and stored before the patient receives conditioning treatment, after which the collected cells are returned to the patient's body.
This approach may be considered for selected diseases and treatment plans.
An allogeneic transplant uses blood-forming stem cells obtained from another person who is considered an appropriate donor.
Donor selection and compatibility assessment are important parts of the treatment process, and the transplant team evaluates the most suitable donor option according to the patient's circumstances.
For an allogeneic transplant, potential donors may undergo detailed medical and compatibility assessment.
The transplant team evaluates relevant biological factors and donor health to identify an appropriate donor when possible.
Before stem cell infusion, patients may receive conditioning treatment designed to prepare the body and bone marrow for transplantation.
The type and intensity of conditioning depend on the underlying disease, transplant approach, patient's health, and individualized treatment plan.
Following conditioning, the collected stem cells are administered through an intravenous infusion.
The transplanted cells can then travel to the bone marrow and begin the process of producing new blood cells.
After transplantation, the medical team closely monitors the patient while the transplanted stem cells establish themselves and begin producing blood cells.
Blood counts and other laboratory parameters are regularly monitored during this period.
Following transplantation, the immune system may be significantly weakened. Patients therefore require careful monitoring for infections and other complications.
Preventive medications, laboratory monitoring, hygiene measures, and other supportive strategies may be used according to the patient's clinical needs.
Patients receiving an allogeneic transplant may be monitored for graft-versus-host disease, a condition in which donor immune cells react against the recipient's tissues.
The transplant team monitors for potential symptoms and may provide treatment or preventive therapy when clinically appropriate.
Supportive care is an important component of bone marrow transplantation. Depending on the patient's needs, care may include blood product support, infection management, nutritional support, medication management, pain control, and monitoring of organ function.
Bone marrow transplant patients require ongoing medical follow-up after leaving the hospital.
Follow-up may include blood tests, disease monitoring, medication review, immune system assessment, and evaluation for delayed complications or recurrence of the underlying disease.
Bone marrow transplant care may involve hematologists, oncologists, transplant physicians, nurses, pharmacists, laboratory specialists, infectious disease specialists, nutrition professionals, and other healthcare providers.
Coordinated care helps address the complex medical needs associated with transplantation.
Patients who have been advised to undergo bone marrow transplantation may seek a specialist second opinion regarding treatment options, transplant suitability, donor selection, or the recommended treatment pathway.
A review of previous medical records, laboratory results, pathology reports, imaging, and treatment history may support further evaluation.
International patients seeking bone marrow transplant evaluation may be required to provide pathology reports, blood test results, imaging studies, previous treatment records, medication information, and other relevant medical documents.
Treatment arrangements are subject to applicable eligibility, referral, appointment, donor, and hospital requirements.
Potential benefits of specialized bone marrow transplant care include:
Comprehensive transplant evaluation
Specialist assessment of serious blood disorders
Evaluation of autologous and allogeneic transplant options
Donor compatibility assessment
Specialized conditioning and transplant planning
Close monitoring during engraftment
Infection and complication management
Long-term disease monitoring
Multidisciplinary supportive care
Individualized treatment planning
Cleveland Clinic provides specialized hematology, oncology, and transplant care within a multidisciplinary healthcare environment. Patients requiring complex blood and bone marrow treatment may receive coordinated assessment involving hematologists, oncologists, transplant specialists, laboratory professionals, and supportive care teams.
For appropriately selected patients, specialist evaluation can help determine whether bone marrow transplantation or another treatment pathway may be suitable.
The overall cost of bone marrow transplantation depends on the patient's diagnosis, transplant type, donor requirements, conditioning treatment, laboratory investigations, hospitalization, medications, supportive care, and follow-up requirements.
Because treatment requirements vary between patients, this service is offered at Price on Request following appropriate medical assessment.
Bone marrow transplantation may be considered for selected patients with certain blood cancers, bone marrow disorders, immune conditions, and other serious diseases when transplantation is medically appropriate.
An autologous transplant uses the patient's own collected stem cells, while an allogeneic transplant uses stem cells from a suitable donor.
Recovery varies depending on the patient's diagnosis, transplant type, overall health, complications, and response to treatment. Long-term follow-up is generally required.
Potential complications may include infections, graft-versus-host disease after an allogeneic transplant, organ-related complications, medication effects, and recurrence of the underlying disease. The transplant team monitors patients closely to manage potential complications.
International patients may be considered subject to applicable eligibility, medical assessment, referral, donor-related requirements, appointment, and hospital requirements.
Product Name: Bone Marrow Transplant at Cleveland Clinic
Hospital: Cleveland Clinic
Brand: Cleveland Clinic
Country: United States
Location: Cleveland, Ohio, USA
Specialty: Transplant Medicine
Service Type: Bone Marrow Transplant
Customer-Facing Price: Price on Request
International Patients: Subject to applicable eligibility and transplant requirements
Frequently Bought Together
Products from this Seller
View All
Subscribe our newsletter for coupon, offer and exciting promotional discount..
Share with Friends
Trading is more effective when you share products with friends!Share you link
Share to